А-1-1990/24 - 8 points
First Breast Cancer Forum in Kragujevac
April 11 – April 12, 2025
Hotel “Kragujevac”, Kragujevac, Serbia
*Registration is required if you wish to participate in the congress.
Moderators

Prof. dr Vicko Ferenc

Dr Sanja Milojević

Prof. dr Slobodanka Mitrović

Prof. dr Zoran Radovanović

Dr Ivana Rosić

Dr spec. Jelena Lučić
Lecturers

Prof. Zahraa Al Hilli (USA)
Navigating the Patient Yourney: Breast Cancer Prevention, Treatment and Survivorship

Prof. Bahadir Gulluoglu (Turkey)
The Future of Breast Cancer Management: Will Surgery Prevail as a Cardinal Treatment?

Prof. dr Ivan Jovanović
Our Insight in the Future of Breast Cancer Biotherapy

Prof. dr Biljana Ljujić
The role of genetic testing in the prevention, diagnosis and therapy of breast cancer

Dr sc. med. Dragana Đilas
Radiologically guided markings of non-palpable breast tumors

Dr spec. Jelena Lučić
Optimal choice of neoadjuvant systemic therapy in HR+ HER2- breast cancer

VNS dr sc. med Ivana Božović
How are patients with early triple-negative breast cancer treated today in Serbia?

Prof. dr Ivan Marković
Current challenges in the surgery of the axilla

Dr sc. med. Jasmina Mladenović
Radiotherapy of the axilla – current guidelines and knowledge
Moderators

Prof. Zahraa Al Hilli (USA)

Prof. dr Ivan Marković

Prof. dr Marko Spasić
Debate PROS and CONS

PROS – Klin. asist. dr Nada Santrač
Axillary dissection can be ommited with 1-2 malignant sentinel nodes in early breast cancer
VS

CONS – Doc. dr Miodrag Đorđević

PROS – Doc. dr Neda Milosavljević
Postoperative breast radiotherapy is necessary for every patient with early breast cancer
VS

CONS – Doc. dr Olivera Ivanov

PROS – Prof. dr Aleksandar Karanikolić
Neoadjuvant therapy is beneficial comparing to the adjuvant therapy – from the surgeon`s point of view
VS

CONS – Prof. dr Nebojša Ivanović

PROS – Doc. dr Merima Goran
Double contrast (blue dye + radiocolloid) is the method of choice for marking sentinel lymph nodes
VS

CONS – Prof. dr Darko Zdravković

PROS – NS dr sc. med. Jasmina Nedović
Dual HER2 blockade is necessary after achieving a pathological complete response (pCR)
VS

CONS – Doc. dr Ana Cvetanović

PROS – Dr spec. Vladimir Selaković
The results of oncoplastic and reconstructive breast surgery are the same if they are performed by a general surgeon alone or together with a plastic surgeon
VS

CONS – Prim. dr sc. med Goran Azanjac
Moderators

Dr sc. med. Dragana Đilas

Prof. dr Srđan Nikolić

Dr Vladimir Tvrdišić
Lecturers

Prof. dr Slobodanka Mitrović
The role of the pathologist in the breast cancer miltidiscipllinary team

Dr Sanja Milojević
Do we have agreed recommendations on the frequency of radiological folow-up after the treatment and can we reach a consensus?

Prof. dr Slobodan Milisavljević
The role of the thoracic surgeon in oncoplastic reconstructions of the chest wall in the treatment of malignant breast tumors

Dr Cem Yilmaz (Turkey)
Oncoplastic Breast Surgery: How to Choose the Right Technique for Each Patient?

Prof. Hasan Karanlik (Turkey)
Breast Conservation in Difficult Cases: Extreme Oncoplasty
Breast Surgery

Moderators – Prof. Bahadir Gulluoglu
(Turkey)

Surgeon – Prof. Hasan Karanlik
(Turkey)

Moderators – Prof. Zahraa Al Hilli
(USA)

Surgeon – Dr Cem Yilmaz
(Turkey)
General sponsor

Gold sponsor

Silver sponsor


Bronze sponsors



Other sponsors






